Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring and responding to new microbial threats to blood safety.  The Book was edited by Hua Shan and Roger Dodd and recently published by Springer. RSI’s Anne Wiles, is lead author for…

IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We are pleased to see inclusion of some of the work RSI’s Drs Franco Momoli and Daniel Krewski conducted for the INTERPHONE and MOBI-Kids studies of cell phones, radiofrequencies, and brain…

Calvin C. Willhite, an Associate Expert with Risk Sciences International working on a range of toxicological risk issues, was just announced as the recipient of the prestigious 2021 Arnold Lehman Award presented annually by the Society of Toxicology for outstanding contributions to evidence-based toxicology to improve public health. Dr. Willhite specializes in human health risk assessments for man-made…

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the increasing focus on evidence based treatment the use of compounded medications substantially decreased.  However, in some therapeutic areas, such as menopause, use of compounded medications continues.  The continuation of use…

RSI’s Emma Hartnett has been selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts for a term of 5 years (2018 to 2022). JEMRA is an international scientific expert group that is administered jointly by the Food and Agriculture Organization of the United Nations (FAO) and…

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski, recently published a series of three papers on investigating the risk of acute liver failure (ALF) following systemic administration of quinolones, based on a synthesis of evidence from available clinical…

Risk Sciences International will host Abdallah Alami as an intern in statistics with support from the Mitacs Accelerate program. This unique university-industry program supports interns at Canadian companies while completing graduate their training at Canadian universities.    Mr. Alami will be completing his MSc in statistics at Carleton University under the supervision of Professor Patrick Farrell and…

Engineers Canada has retained Risk Sciences International’s (RSI) Climate Group to develop training course modules and to deliver on-line training to Professional Engineers seeking to achieve their Infrastructure Resilience Professional (IRP) certification. Recognizing that not all candidates seeking their IRP can attend workshops and courses by travel to in-person training events, Engineers Canada has established…

The OPTrust Climate Change Symposium being held NOVEMBER 19-20, 2018 in TORONTO offers an opportunity to provide new insights into how to face climate change and thrive in an era of disruption. Climate change is one of the most significant challenges facing the world today and increasingly complex to navigate. Despite years of debate, a…

Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski evaluated the potential risk of retinal detachment (RD) associated with these medications. Although no cases of RD were linked to quinolones in clinical trials, some reports of RD were noted…